Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Biomimetic nanovesicles can speed up diabetic wound healing by regulating immune cell behavior and metabolism.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

Recent selection on immune response genes was identified across seven ethnicities.

Niosomes are a promising, stable, and cost-effective drug delivery system with potential for improved targeting and safety.

Nanoparticle systems make cancer treatment less toxic.

Understanding hair follicle signaling can improve hair disorder treatments.

This method is effective for needle-free HIV-1 vaccination by activating immune responses in the skin.

NDP-MSH protects brain cells and reduces inflammation in Parkinson's disease by activating MC1R and involving Tregs.

Adiponectin and bradykinin play important roles in skin health and may help treat skin conditions.

Early intervention with JAK inhibitors may prevent alopecia areata progression.

Nanoparticles can improve skin treatments by better targeting hair follicles, but more research is needed for advancement.

Hair loss may link to weaker COVID-19 immunity, suggesting possible need for extra vaccine boost.

More research is needed to understand and manage rheumatoid arthritis better.

Microsponges delivery system is a safe, versatile method for controlled drug release in various treatments.

The human hair follicle can store topical compounds and be targeted for drug delivery with minimal side effects.

Ionizable lipid nanoparticles are the best for delivering gene-editing therapies.

Peptide nanoparticles can effectively deliver CRISPR-Cas9 to target KRAS mutations in cancer.

The N-K GM Series offers highly selective, eco-friendly medicines targeting harmful microbes, free for personal use.

Targeting macrophages may improve wound healing.

Alopecia areata involves immune system issues and specific cell types that disrupt hair growth, leading to hair loss.

Basal cell carcinomas may use IDO to protect themselves from the immune system.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Targeting TRP channels may help reduce excessive scarring.

Targeting EMT and fibrotic remodeling may help treat androgenetic alopecia.

Targeting Vδ1+T-cells may help treat alopecia areata.

Improving PROTAC delivery systems can enhance their effectiveness and speed up their use in medicine.

CRH in the skin acts like the body's stress response system, affecting cell behavior and immune activity.

Pantethine may boost the immune system's ability to fight sarcoma.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

CRISPR/Cas systems show promise for cancer treatment by targeting miRNAs, but delivery and specificity challenges remain.